GlaxoSmithKline Pharmaceuticals Statistics
Total Valuation
GlaxoSmithKline Pharmaceuticals has a market cap or net worth of INR 477.37 billion. The enterprise value is 458.99 billion.
Market Cap | 477.37B |
Enterprise Value | 458.99B |
Important Dates
The next estimated earnings date is Friday, November 8, 2024.
Earnings Date | Nov 8, 2024 |
Ex-Dividend Date | May 31, 2024 |
Share Statistics
GlaxoSmithKline Pharmaceuticals has 169.41 million shares outstanding. The number of shares has increased by 0.03% in one year.
Shares Outstanding | 169.41M |
Shares Change (YoY) | +0.03% |
Shares Change (QoQ) | +0.03% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | 8.18% |
Float | 41.37M |
Valuation Ratios
The trailing PE ratio is 74.60 and the forward PE ratio is 54.13.
PE Ratio | 74.60 |
Forward PE | 54.13 |
PS Ratio | 13.62 |
PB Ratio | 26.85 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 71.71 |
EV / Sales | 13.09 |
EV / EBITDA | 46.59 |
EV / EBIT | 49.59 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 1.05 |
Debt / EBITDA | 0.02 |
Debt / FCF | n/a |
Interest Coverage | 490.08 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | 32.56% |
Revenue Per Employee | 10.92M |
Profits Per Employee | 1.99M |
Employee Count | 3,211 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +92.97% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +92.97% |
50-Day Moving Average | 2,745.83 |
200-Day Moving Average | 2,275.04 |
Relative Strength Index (RSI) | 50.27 |
Average Volume (20 Days) | 5,618 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, GlaxoSmithKline Pharmaceuticals had revenue of INR 35.07 billion and earned 6.40 billion in profits. Earnings per share was 37.77.
Revenue | 35.07B |
Gross Profit | 21.52B |
Operating Income | 9.26B |
Pretax Income | 8.85B |
Net Income | 6.40B |
EBITDA | 9.68B |
EBIT | 9.26B |
Earnings Per Share (EPS) | 37.77 |
Balance Sheet
The company has 18.57 billion in cash and 186.65 million in debt, giving a net cash position of 18.38 billion or 108.51 per share.
Cash & Cash Equivalents | 18.57B |
Total Debt | 186.65M |
Net Cash | 18.38B |
Net Cash Per Share | 108.51 |
Equity (Book Value) | 17.78B |
Book Value Per Share | 104.93 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 61.38%, with operating and profit margins of 26.40% and 18.25%.
Gross Margin | 61.38% |
Operating Margin | 26.40% |
Pretax Margin | 25.23% |
Profit Margin | 18.25% |
EBITDA Margin | 27.59% |
EBIT Margin | 26.40% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 32.00, which amounts to a dividend yield of 1.14%.
Dividend Per Share | 32.00 |
Dividend Yield | 1.14% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.03% |
Shareholder Yield | 1.10% |
Earnings Yield | 1.34% |
FCF Yield | n/a |
Stock Splits
The last stock split was on September 11, 2018. It was a forward split with a ratio of 2.
Last Split Date | Sep 11, 2018 |
Split Type | Forward |
Split Ratio | 2 |